For Prostate Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.
For Prostate Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space:
Following the Food and Drug Administration’s recent approval of Nubeqa (darolutamide), men with non-metastatic castration-resistant prostate cancer now have an earlier more precise treatment option.
Newly diagnosed? This piece gathers the best advice about prostate cancer from the men and families who have already gone through it.
Men with advanced prostate cancer may benefit from genomic testing as BRCA and other gene mutations play a bigger role in guiding treatment.
After taking up running at age 63, Andy Steinfeldt was diagnosed with prostate cancer a few years later. But he didn’t let it slow him down. Listen to our podcast interview with Andy, who looks at cancer “as a motivation rather than a destination."
The Prostate Cancer Foundation recently announced a host of new free resources for patients and their families to ensure they can make the best treatment choices.